These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17354258)

  • 1. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z; Erdogan M; Tetik A; Karadeniz M; Cetinalp S; Kosova B; Gunduz C; Ozgen AG; Yilmaz C
    Diabetes Metab Res Rev; 2007 Nov; 23(8):621-4. PubMed ID: 17354258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
    Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
    Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
    Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z; Cetinkalp S; Erdogan M; Kosova B; Karadeniz M; Kutukculer A; Gunduz C; Tetik A; Topcuoglu N; Ozgen AG; Tuzun M
    J Diabetes Complications; 2008; 22(3):186-90. PubMed ID: 18413162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus.
    Hasegawa G; Obayashi H; Kamiuchi K; Nakai M; Kanatsuna T; Yamaguchi M; Tanaka T; Shigeta H; Fujii M; Yoshikawa T; Nakamura N
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):132-8. PubMed ID: 12784186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
    Böger CA; Stubanus M; Haak T; Götz AK; Christ J; Hoffmann U; Riegger GA; Krämer BK
    Nephrol Dial Transplant; 2007 Jan; 22(1):154-62. PubMed ID: 17005529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
    Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
    Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy in Croatian type 2 diabetic patients.
    Tomić NG; Marusić S; Bozikov V; Kusec R; Bacić-Vrca V; Tadić M
    Coll Antropol; 2013 Sep; 37(3):789-93. PubMed ID: 24308218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase gene polymorphisms c.677C/T and c.1298A/C are not associated with open angle glaucoma.
    Mabuchi F; Tang S; Kashiwagi K; Yamagata Z; Iijima H; Tsukahara S
    Mol Vis; 2006 Jul; 12():735-9. PubMed ID: 16862068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients.
    Santos KG; Canani LH; Gross JL; Tschiedel B; Souto KE; Roisenberg I
    J Nephrol; 2005; 18(6):733-8. PubMed ID: 16358232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease.
    Yilmaz H; Isbir S; Agachan B; Ergen A; Farsak B; Isbir T
    Cell Biochem Funct; 2006; 24(1):87-90. PubMed ID: 15648053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on homocysteine levels and methylenetetrahydrofolate reductase gene variant (C677T) in a population of Buenos Aires City.
    Fridman O; Porcile R; Vanasco V; Junco MN; Gariglio L; Potenzoni MA; Bañes I; Morales A
    Clin Exp Hypertens; 2008 Oct; 30(7):574-84. PubMed ID: 18855261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
    Tutuncu NB; Erbas T; Alikasifoglu M; Tuncbilek E
    J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.
    El-Baz R; Settin A; Ismaeel A; Khaleel AA; Abbas T; Tolba W; Abd Allah W; Sobh MA
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.
    Sun J; Xu Y; Zhu Y; Lu H
    Diabetes Res Clin Pract; 2004 Jun; 64(3):185-90. PubMed ID: 15126006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients.
    Shcherbak NS; Shutskaya ZV; Sheidina AM; Larionova VI; Schwartz EI
    Mol Genet Metab; 1999 Nov; 68(3):375-8. PubMed ID: 10562465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
    Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.